Found: 16
Select item for more details and to access through your institution.
Review of the safety and efficacy of ustekinumab.
- Published in:
- Therapeutic Advances in Gastroenterology, 2010, v. 3, n. 5, p. 321, doi. 10.1177/1756283X10374216
- By:
- Publication type:
- Article
Short Chain Fatty Acids Modulate the Growth and Virulence of Pathosymbiont Escherichia coli and Host Response.
- Published in:
- Antibiotics (2079-6382), 2020, v. 9, n. 8, p. 462, doi. 10.3390/antibiotics9080462
- By:
- Publication type:
- Article
Digital Health Apps in the Clinical Care of Inflammatory Bowel Disease: Scoping Review.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Ustekinumab is effective and safe for ulcerative colitis through 2 years of maintenance therapy.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2020, v. 52, n. 11/12, p. 1658, doi. 10.1111/apt.16119
- By:
- Publication type:
- Article
Safety and Efficacy of a New 3.3 g b.i.d. Tablet Formulation in Patients With Mild-to-Moderately-Active Ulcerative Colitis: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study.
- Published in:
- American Journal of Gastroenterology (Springer Nature), 2009, v. 104, n. 6, p. 1452, doi. 10.1038/ajg.2009.83
- By:
- Publication type:
- Article
Vitamin C Deficiency: An Under-Recognized Condition in Crohn's Disease.
- Published in:
- ACG Case Reports Journal, 2020, v. 7, n. 7, p. 1, doi. 10.14309/crj.0000000000000424
- By:
- Publication type:
- Article
Inflammation Drives Dysbiosis and Bacterial Invasion in Murine Models of Ileal Crohn's Disease.
- Published in:
- PLoS ONE, 2012, v. 7, n. 7, p. 1, doi. 10.1371/journal.pone.0041594
- By:
- Publication type:
- Article
Increased Primary Bile Acids with Ileocolonic Resection Impact Ileal Inflammation and Gut Microbiota in Inflammatory Bowel Disease.
- Published in:
- Journal of Crohn's & Colitis, 2023, v. 17, n. 5, p. 795, doi. 10.1093/ecco-jcc/jjac173
- By:
- Publication type:
- Article
Efficacy and Safety of Maintenance Ustekinumab for Ulcerative Colitis Through 3 Years: UNIFI Long-term Extension.
- Published in:
- Journal of Crohn's & Colitis, 2022, v. 16, n. 8, p. 1222, doi. 10.1093/ecco-jcc/jjac030
- By:
- Publication type:
- Article
5-Aminosalicylic acid downregulates the growth and virulence of Escherichia coli associated with IBD and colorectal cancer, and upregulates host anti-inflammatory activity.
- Published in:
- Journal of Antibiotics, 2018, v. 71, n. 11, p. 950, doi. 10.1038/s41429-018-0081-8
- By:
- Publication type:
- Article
Rifaximin decreases virulence of Crohn’s disease-associated Escherichia coli and epithelial inflammatory responses.
- Published in:
- Journal of Antibiotics, 2018, v. 71, n. 5, p. 485, doi. 10.1038/s41429-017-0022-y
- By:
- Publication type:
- Article
Pneumocystis jiroveci pneumonia with recurrent pneumothorax requiring pleurodesis in inflammatory bowel disease.
- Published in:
- Journal of Digestive Diseases, 2015, v. 16, n. 7, p. 416, doi. 10.1111/1751-2980.12257
- By:
- Publication type:
- Article
Cerebral venous thrombosis in inflammatory bowel disease.
- Published in:
- Journal of Digestive Diseases, 2015, v. 16, n. 2, p. 104, doi. 10.1111/1751-2980.12212
- By:
- Publication type:
- Article
The Cost-Effectiveness of Vedolizumab for Inflammatory Bowel Disease: A Review of the Current Literature.
- Published in:
- Gastroenterology & Hepatology, 2016, v. 12, n. 10, p. 617
- By:
- Publication type:
- Article
Exercise and Self-Reported Limitations in Patients with Inflammatory Bowel Disease.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Patient-Preferences Favoring Treatment Discontinuation Are Reduced With Vedolizumab and Ustekinumab Compared With TNF Antagonists in Inflammatory Bowel Disease.
- Published in:
- Crohn's & Colitis 360, 2020, v. 2, n. 4, p. 1, doi. 10.1093/crocol/otaa074
- By:
- Publication type:
- Article